Cargando…
The Role of Convalescent Plasma and Tocilizumab in the Management of COVID-19 Infection: A Cohort of 110 Patients from a Tertiary Care Hospital in Oman
Aim: As Coronavirus Disease-2019 (COVID-19) pandemic continues to evolve, the search for safe and effective therapeutic interventions remain essential. Methods: We conducted a retrospective cohort study on patients hospitalized with laboratory confirmed severe acute respiratory syndrome coronavirus-...
Autores principales: | Khamis, Faryal, Memish, Ziad, Al Bahrani, Maher, Al Nummani, Hamed, Al Raisi, Dana, Al Dowaiki, Samata, Chhetri, Shabnam, Al Fahdi, Fatma, Al Yahyai, Maha, Pandak, Nenad, Al Bolushi, Zakariya, Alarimi, Zainab, Al Hashmi, Sabria, Al Salmi, Issa, Al-Zakwani, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242118/ https://www.ncbi.nlm.nih.gov/pubmed/33605108 http://dx.doi.org/10.2991/jegh.k.201222.001 |
Ejemplares similares
-
Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection
por: Khamis, Faryal, et al.
Publicado: (2021) -
Therapeutic plasma exchange in adults with severe COVID-19 infection
por: Khamis, Faryal, et al.
Publicado: (2020) -
Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021) -
Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010–2020) in Oman
por: Khamis, Faryal, et al.
Publicado: (2022) -
Clinical characteristics and outcomes of the first 63 adult patients hospitalized with COVID-19: An experience from Oman
por: Khamis, Faryal, et al.
Publicado: (2020)